O. Karayal

发表

Switching from Quetiapine to Ziprasidone: A Sixteen-Week, Open-Label, Multicenter Study Evaluating the Effectiveness and Safety of Ziprasidone in Outpatient Subjects with Schizophrenia or Schizoaffective Disorder

I. Cavus, O. Karayal, P. Glue, 2011, Journal of psychiatric practice.

maintenancetreatmentofbipolarIdisorder:Long-term changes in weight and metabolic profiles

J. Calabrese, G. Sachs, E. Vieta, 2012 .

Ziprasidone in the Treatment of Bipolar Disorder

S. Stahl, O. Karayal, T. Schwartz, 2011 .

Clinical, ECG and echocardiographic clues to the diagnosis of TTR-related cardiomyopathy

C. Rapezzi, M. Maurer, O. Karayal, 2016, Open Heart.

THAOS: Gastrointestinal manifestations of transthyretin amyloidosis - common complications of a rare disease

O. Karayal, O. Suhr, J. Wixner, 2014, Orphanet Journal of Rare Diseases.

Risk for Adverse Events and Discontinuation Due To Adverse Events of Ziprasidone Monotherapy Relative to Placebo in the Acute Treatment of Bipolar Depression, Mania, and Schizophrenia

J. Calabrese, K. Gao, O. Karayal, 2013, Journal of clinical psychopharmacology.

Intramuscular Ziprasidone Versus Haloperidol for Managing Agitation in Chinese Patients With Schizophrenia

Hongyan Zhang, Jingping Zhao, Xiufeng Xu, 2013, Journal of clinical psychopharmacology.

Completed and attempted suicides among 18,154 subjects with schizophrenia included in a large simple trial.

J. Kane, W. Fleischhacker, B. Strom, 2014, The Journal of clinical psychiatry.

Ziprasidone and the Corrected QT Interval

T. Tensfeldt, A. Camm, J. Kane, 2012, CNS Drugs.

Regional disease characteristics and comorbidities of patients with schizophrenia in the Ziprasidone Observational Study of Cardiac Outcomes (ZODIAC): Findings from an international large simple trial

J. Kane, W. Fleischhacker, B. Strom, 2012 .

Relating Spontaneously Reported Extrapyramidal Adverse Events to Movement Disorder Rating Scales

G. Kemmler, C. Widschwendter, O. Karayal, 2015, The international journal of neuropsychopharmacology.

Metabolic risk factors in first-episode schizophrenia: baseline prevalence and course analysed from the European First-Episode Schizophrenia Trial.

R. Kahn, W. Fleischhacker, O. Karayal, 2013, The international journal of neuropsychopharmacology.

Ziprasidone with adjunctive mood stabilizer in the maintenance treatment of bipolar I disorder: Long-term changes in weight and metabolic profiles

J. Calabrese, G. Sachs, E. Vieta, 2012, European Neuropsychopharmacology.

Post Hoc Analysis of Nutritional Status in Patients with Transthyretin Familial Amyloid Polyneuropathy: Impact of Tafamidis

O. Karayal, I. Conceição, O. Suhr, 2014, Neurology and Therapy.

Adjunctive oral ziprasidone in patients with acute mania treated with lithium or divalproex, part 2: influence of protocol-specific eligibility criteria on signal detection.

G. Sachs, I. Cavus, O. Karayal, 2012, The Journal of clinical psychiatry.

Adjunctive oral ziprasidone in patients with acute mania treated with lithium or divalproex, part 1: results of a randomized, double-blind, placebo-controlled trial.

G. Sachs, I. Cavus, O. Karayal, 2012, The Journal of clinical psychiatry.

Characterizing relapse prevention in bipolar disorder with adjunctive ziprasidone: clinical and methodological implications.

C. Bowden, O. Karayal, J. Schwartz, 2013, Journal of affective disorders.

Effect of ziprasidone dose on all-cause discontinuation rates in acute schizophrenia and schizoaffective disorder: A post-hoc analysis of 4 fixed-dose randomized clinical trials

L. Citrome, O. Karayal, P. Glue, 2009, Schizophrenia Research.

Efficacy and tolerability of switching to ziprasidone from olanzapine, risperidone or haloperidol: an international, multicenter study

O. Karayal, H. E. Tallawy, C. Akkaya, 2009, International clinical psychopharmacology.

PRIMARY AND READJUDICATION MORTALITY RESULTS FROM ZODIAC, A LARGE SIMPLE TRIAL OF ZIPRASIDONE VS. OLANZAPINE IN PATIENTS WITH SCHIZOPHRENIA

R. D'Agostino, J. Ruskin, J. Kane, 2010, Schizophrenia Research.

Ziprasidone and the relative risk of diabetes

O. Karayal, E. Pappadopulos, D. Keohane, 2011, British Journal of Psychiatry.

Clinical and echocardiographic signs associated with increased interventricular thickness (IVST) due to TTR related amyloidosis

O. Karayal, V. Planté-Bordeneuve, A. Kristen, 2013 .

Methodological challenges in the coding and adjudication of sudden deaths in a large simple trial with observational follow‐up: the ziprasidone observational study of cardiac outcomes (ZODIAC)

J. Camm, B. Strom, O. Karayal, 2011, Pharmacoepidemiology and drug safety.